Historical Valuation
EUDA Health Holdings Ltd (EUDA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 5.15 is considered Undervalued compared with the five-year average of -11.35. The fair price of EUDA Health Holdings Ltd (EUDA) is between 6.12 to 10.19 according to relative valuation methord. Compared to the current price of 2.31 USD , EUDA Health Holdings Ltd is Undervalued By 62.27%.
Relative Value
Fair Zone
6.12-10.19
Current Price：2.31
62.27%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
EUDA Health Holdings Ltd (EUDA) has a current Price-to-Book (P/B) ratio of -24.64. Compared to its 3-year average P/B ratio of -16.81 , the current P/B ratio is approximately 46.60% higher. Relative to its 5-year average P/B ratio of -12.70, the current P/B ratio is about 94.04% higher. EUDA Health Holdings Ltd (EUDA) has a Forward Free Cash Flow (FCF) yield of approximately -2.31%. Compared to its 3-year average FCF yield of -2.88%, the current FCF yield is approximately -19.70% lower. Relative to its 5-year average FCF yield of -3.67% , the current FCF yield is about -37.17% lower.
P/B
Median3y
-16.81
Median5y
-12.70
FCF Yield
Median3y
-2.88
Median5y
-3.67
Competitors Valuation Multiple
AI Analysis for EUDA
The average P/S ratio for EUDA competitors is 53.94, providing a benchmark for relative valuation. EUDA Health Holdings Ltd Corp (EUDA.O) exhibits a P/S ratio of 5.15, which is -90.46% above the industry average. Given its robust revenue growth of -95.71%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for EUDA
1Y
3Y
5Y
Market capitalization of EUDA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of EUDA in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is EUDA currently overvalued or undervalued?
EUDA Health Holdings Ltd (EUDA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 5.15 is considered Undervalued compared with the five-year average of -11.35. The fair price of EUDA Health Holdings Ltd (EUDA) is between 6.12 to 10.19 according to relative valuation methord. Compared to the current price of 2.31 USD , EUDA Health Holdings Ltd is Undervalued By 62.27% .
What is EUDA Health Holdings Ltd (EUDA) fair value?
EUDA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of EUDA Health Holdings Ltd (EUDA) is between 6.12 to 10.19 according to relative valuation methord.
How does EUDA's valuation metrics compare to the industry average?
The average P/S ratio for EUDA's competitors is 53.94, providing a benchmark for relative valuation. EUDA Health Holdings Ltd Corp (EUDA) exhibits a P/S ratio of 5.15, which is -90.46% above the industry average. Given its robust revenue growth of -95.71%, this premium appears unsustainable.
What is the current P/B ratio for EUDA Health Holdings Ltd (EUDA) as of Jan 10 2026?
As of Jan 10 2026, EUDA Health Holdings Ltd (EUDA) has a P/B ratio of -24.64. This indicates that the market values EUDA at -24.64 times its book value.
What is the current FCF Yield for EUDA Health Holdings Ltd (EUDA) as of Jan 10 2026?
As of Jan 10 2026, EUDA Health Holdings Ltd (EUDA) has a FCF Yield of -2.31%. This means that for every dollar of EUDA Health Holdings Ltd’s market capitalization, the company generates -2.31 cents in free cash flow.
What is the current Forward P/E ratio for EUDA Health Holdings Ltd (EUDA) as of Jan 10 2026?
As of Jan 10 2026, EUDA Health Holdings Ltd (EUDA) has a Forward P/E ratio of 42.78. This means the market is willing to pay $42.78 for every dollar of EUDA Health Holdings Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for EUDA Health Holdings Ltd (EUDA) as of Jan 10 2026?
As of Jan 10 2026, EUDA Health Holdings Ltd (EUDA) has a Forward P/S ratio of 5.15. This means the market is valuing EUDA at $5.15 for every dollar of expected revenue over the next 12 months.